Here are relevant reports on : home-decor-market
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers), Wounds (Chronic, Acute)), End User (Hospitals, Clinics, Home Care), and Region -Global Forecast to 2030
The global wound care market, valued at US$20.97 billion in 2024, stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions.
- Published: July 2025
- Price: $ 8150
- TOC Available:
-
Surfactants Market by Type (Anionic, Non-ionic, Cationic & Amphoteric), Application (Home Care, Personal Care, Industrial & Institutional Cleaning, Textile, Elastomers & Plastics, Agrochemicals, and Food & Beverage), and Region - Global Forecast to 2028
The surfactants market is expected to grow from USD 43.5 billion in 2022 to USD 57.8 billion by 2028, at a CAGR of 4.9% during the forecast period. The key players profiled in the report include BASF SE (Germany), Stepan Company (US), Evonik Industries AG (Germany), Dow Inc. (US), Nouryon (Netherlands), and Solvay S.A. (Belgium).
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Electronic Sensors Market For Consumer Industry by Type (Image, Motion, Pressure, Temperature, Fingerprint, Proximity, & Others), Application (Communication & IT, Entertainment, Home Appliances, & Wearable Devices), and Geography - Global Forecast to 2022
The electronic sensors market for consumer industry is expected to reach USD 26.76 Billion by 2022, at a CAGR of 12.26% between 2016 and 2022. Market players involved in the manufacturing of electronic sensors include Sony Corporation (Japan), Samsung Electronics Co., Ltd.(South Korea), STMicroelectronics N.V.(Switzerland), NXP Semiconductors N.V.,(acquired by Qualcomm), TE Connectivity Ltd. (Switzerland), Murata Manufacturing Co., Ltd.(Japan), Robert Bosch GmbH (Germany), Infineon Technologies AG (Germany), Synaptics Incorporated (US) Cypress Semiconductor Corporation (US) and Omron Corporation (Japan) are focusing on product launches, research and development, acquisitions, and collaborations to enhance their product offerings and business expansion.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Wireless Audio Device Market by Product (True Wireless Hearables/Earbuds, Headsets, Earphones), Technology (Bluetooth, Airplay, Wi-Fi), Application (Consumer, Home Audio, Automotive), Functionality (Smart, Non-smart) and Region - Global Forecast to 2029
The Wireless Audio Device Market is expected to grow from USD 56.5 billion in 2024 to USD 70.9 billion by 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period.The key players Apple Inc (US), SAMSUNG (South Korea), Bose Corporation (US), Sonos, Inc. (US), Sony Corporation (Japan).
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) & Region - Global Forecast to 2029
The global hemodialysis and peritoneal dialysis market, valued at US$87.2 billion in 2023, stood at US$92.0 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$126.2 billion by the end of the period. This growth is driven by the rising prevalence of chronic kidney disease (CKD), particularly due to aging populations and increasing rates of diabetes and hypertension.
- Published: April 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
